Powered by

Switzerland's Roche to buy Ariosa Diagnostics

Dec 02, 2014 - The Deal Pipeline
Mergers and Acquisitions

Swiss pharmaceuticals maker Roche Holding AGon Tuesday. Dec. 2, said it would acquire Ariosa Diagnostics Inc., a San Jose, Calif., company best known for its Harmony fetal blood test for Down syndrome and other genetic abnormalities. The privately held company's backers include Venrock. Roche, of Basel, said the acquisition is expected to close later this month. A Latham & Watkins LLP team led by Charles Ruck and Scott Shean advised Ariosa. - Laura Board


$ 50 Billion and U...